Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New treatments for multiple sclerosis: at what long-term risk?
Emerging Subspecialties in Neurology: Palliative care.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
What do healthcare providers advise women with multiple sclerosis regarding pregnancy?
[A different approach to the care of patients with MS].
[Pathogenesis of neuromyelitis optica].
Symptomatic Sinus Bradycardia After a Treatment Course Of High-dose Oral Prednisone.
Neuromyelitis optica and pregnancy.
Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.
Early onset (childhood) monogenic neuropathies.
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil.
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
[Neuropathology of multiple sclerosis].
Multiple Sclerosis from Bench to Bedside.
Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity.
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
PET imaging in multiple sclerosis.
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Laminar cortical damage in multiple sclerosis.
Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial.
No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability.

Pages